Announcements Trials
Browse Landscape

Phase

Phase NA 22Phase 2 4Phase 4 3Phase 3 3Phase 2/3 2Phase 1 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Other neoplasm 1

Conditions

Small Cell Lung Carcinoma 1Precancerous Conditions 1Polycystic Ovary Syndrome 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Inositol × Clear all
NCT07459595 2026-03-10

Metformin Versus Myo-inositol in the Management of Polycystic Ovarian Disease: A Comparative Study

Combined Military Hospital Gujranwala

Phase 1 Not yet recruiting
60 enrolled

Polycystic Ovary Syndrome

NCT00061997 2010-02-02

Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers

National Cancer Institute (NCI)

Phase 1 Completed
Other neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Precancerous Conditions, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡